Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00020007 · ClinicalTrials.gov registry record · Phase 1
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
A Phase 1 study of Lung Cancer and Metastatic Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Study locations
NCT00020007: Completed Phase 1 study of Lung Cancer and Metastatic Cancer, sponsored by National Cancer Institute (NCI).
NCT00020007 is a Phase 1 study of Lung Cancer and Metastatic Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00020007, a Phase 1 study of Lung Cancer and Metastatic Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Heating paclitaxel to several degrees above body temperature and infusing it to the affected area around the tumor may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of paclitaxel given by hyperthermic perfusion in treating patients with lung cancer or lung metastases that cannot be removed by surgery.
Conditions Studied
Interventions
- DRUG paclitaxel
- DRUG isolated perfusion
- PROCEDURE hyperthermia treatment
Study Locations (2)
Maryland
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda
- NCI - Center for Cancer Research - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-12 |
| Phase | Phase 1 |
What the finished NCT00020007 record still lists
NCT00020007 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which paclitaxel is the first listed.
NCT00020007 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00020007 about?
NCT00020007 is a clinical study titled "Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Heating paclitaxel to several degrees above body temperature and infusing it to the affected area around the tumor may kill more tumor cells. PURPOSE: This phase I trial is studyi...
What is the current status of trial NCT00020007?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-12.
What conditions does trial NCT00020007 study?
This clinical trial studies the following conditions: Lung Cancer, Metastatic Cancer.
What interventions are being tested in trial NCT00020007?
The interventions under investigation include: paclitaxel (DRUG), isolated perfusion (DRUG), hyperthermia treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00020007?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00020007 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia